Hims & Hers stock price jumps: Telehealth company acquires Zava, picking up over a million Europe customers
American telehealth company Hims & Hers Health announced on Tuesday that it will be acquiring Zava, a leading European digital health company in an all cash acquisition set to close in the second half of 2025. Following the announcement, Hims' stock price (HIMS) jumped 5.8% in premarket trading. (As of midday Tuesday, the stock was trading up just under one point.)
The move will rapidly expand Hims & Hers' reach, which has a current base of 2.4 million U.S. customers. As the only digital health company with over a decade of operations across Germany, France, Ireland, and the U.K., Zava has an active user base of 1.3 million.
'The demand for simpler, more personalized healthcare is universal,' said Andrew Dudum, founder and CEO of Hims & Hers, in a press release. 'By leveraging Zava's established European presence, cutting-edge technology, and deep customer understanding, we're poised to fundamentally transform access to care for millions across Europe. Whether in rural towns, vibrant cities, or remote communities across Europe, people battling widespread, often silent chronic conditions like obesity, depression, and more will have access to the personalized, high-quality care they deserve.'
Expanding to Europe is additionally beneficial because the E.U.'s universal healthcare policies make pharmaceuticals much more affordable relative to the U.S. This means that personalized telehealth services like Hims & Hers could become more widely accessible there.
'The medications are priced more competitively than in the U.S. so more people can actually afford it and we are seeing a huge demand,' said Zava CEO David Meinertz in an interview with CNBC. 'The demand is increasing with additional strains on the statutory systems that telehealth can alleviate.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
38 minutes ago
- Wall Street Journal
Ireland's Economy Grew Much Faster Than Expected on Tariff Stockpiling
Ireland's economy grew three times as rapidly as first estimated in the first quarter, driven by stockpiling of pharmaceuticals and other goods by U.S. businesses ahead of threatened tariffs. The huge revision in output announced by the country's statistics agency Thursday means the eurozone economy likely grew much faster than previously estimated, with new figures for growth in the three months through March to be released Friday.
Bloomberg
42 minutes ago
- Bloomberg
Vista CEO Says AI to Force 60% of SuperReturn Crowd to Seek Work
Vista Equity Partners ' founder, chairman and CEO Robert F. Smith said he expects AI to have a seismic impact on jobs in the private market industry. 'We think that next year, 40% of the people at this conference will have an AI agent and the remaining 60% will be looking for work,' he said in comments at the SuperReturn International private capital conference in Berlin.
Associated Press
42 minutes ago
- Associated Press
Pampers maker Procter & Gamble to cut up to 7,000 jobs under tariff, consumer uncertainty pressure
Procter & Gamble will cut up to 7,000 jobs, or approximately 6% of its global workforce, over the next two years as the maker of Tide detergent and Pampers diapers wrestles with tariff-related costs and customers who have grown anxious about the economy. The job cuts, announced at the Deutsche Bank Consumer Conference in Paris on Thursday, make up about 15% of its current non-manufacturing workforce, said Chief Financial Officer Andre Schulten. 'This restructuring program is an important step toward ensuring our ability to deliver our long-term algorithm over the coming two to three years,' Schulten said. 'It does not, however, remove the near-term challenges that we currently face.' Procter & Gamble, based in Cincinnati, had approximately 108,000 employees worldwide in June 2024. The cuts are part of a broader restructuring program. Procter & Gamble will also end sales of some of its products in certain markets. Procter & Gamble said it will provide more details about that in July.
